12 NEWS


Innosya reveals debut range of active ingredients


Innosya Cosmetic Ingredients, Lesaffre’s new cosmetic activity, took the wraps off three patented active ingredients made by fermentation at in-cosmetics Global 2026 in Paris. Leveraging the French company’s


170 years of expertise in fermentation and microorganisms, Skinosya Chondro, Skinosya Salidroside and Skinosya SAG offer unique benefits to the cosmetic industry for all life stages. Skinosya Chondro is said to be


the first fermented vegan chondroitin sulfate to replace traditional animal- derived solutions for pro-ageing. Chondroitin sulfate, naturally


occurring in skin, is part of the glycosaminoglycan family like hyaluronic acid. Thanks to its high content


of sulfated groups, this high- performance sodium chondroitin sulfate active is clinically proven to strengthen the skin barrier, stimulate collagen and elastin production, and restore firmness, density and elasticity, while reducing skin sagging. This patented ingredient opens


new perspectives for anti-ageing, pre-juvenating, moisturizing, makeup, men’s care and body care formulations. The second ingredient, Skinosya


Salidroside, is a sustainable alternative to rhodiola root extract for stressed skins.


BASF US biotech tie-ups push collagen forward


BASF unveiled a “new chapter in collagen science” at in-cosmetics Global 2026 with the launch of two skin rejuvenation actives developed in partnership with US biotech specialists. The first, NeoHelix


Regenerate, delivers adaptive collagen rejuvenation for visible improvements in wrinkle appearance and skin tonicity. NeoHelix Regenerate is a


Salidroside is the key active found in rhodiola, a stress-adaptogenic plant on the CITES list (the Convention on International Trade in Endangered Species of Wild Fauna and Flora). Skinosya Salidroside offers a


fermented, sustainable alternative to rhodiola root extract, supporting stressed skin without harming protected plants. Skinosya Salidroside reduces


cortisol secretion, protects mitochondrial network health, prevents inflammatory damage, and reinforces the skin barrier. Clinically tested, this ingredient


is ideal for anti-stress, anti-fatigue, well-being, urban shield, soothing, men’s care and makeup applications. The third ingredient, Skinosya


SAG, is said to be a breakthrough S-Acetyl Glutathione to prevent menopausal ageing. Skinosya SAG is a highly stable


and bioavailable form of glutathione, a vital antioxidant that declines significantly during the menopause. As estrogen levels drop, free


iron accumulates in skin cells while glutathione (GSH) levels decrease significantly, leading to membrane lipid peroxidation and eventually ferroptosis, which accelerates visible signs of ageing. Skinosya SAG is designed to


restore intracellular GSH levels, prevent lipid peroxidation and protein carbonylation responsible for cell death, and to maintain mitochondrial health, and extend skin’s longevity potential.


Chemyunion ingredient takes aim at grey hair


Chemyunion has launched BioTech4 AntiGray (INCI: Lactobacillus Ferment Lysate), a innovative biotechnology-based hair care ingredient designed to stimulates natural melanin and help reverse hair greying. Developed through a proprietary


platform, this postbiotic ingredient acts directly on the biological mechanisms responsible for greying. Rather than simply concealing


grey strands, its approach is to stimulate the natural resumption of melanin production within the hair follicle, progressively restoring the functionality of the hair pigmentation system. The appearance of grey hair is one of the most evident signs of


hair follicles from a 50-year-old male donor, a 43% increase in melanin content in the hair bulb was observed, confirming the ingredient’s ability to stimulate pigmentary activity directly at the root level. An in vivo study conducted with


90 volunteers (men and women aged 20–55) over 120 days, using a formulation containing 3% of the active, demonstrated significant results:


Among the main observed


hair aging and is associated with the progressive decline in melanocyte activity within the hair bulb, often exacerbated by oxidative stress. In an ex vivo model using human


PERSONAL CARE MAGAZINE May 2026


outcomes, 76.7% of participants reported a visible reduction in grey hair, 27% noted an increase in hair colour uniformity, and there was a 90% overall satisfaction after using formulations containing BioTech4 AntiGray.


www.personalcaremagazine.com


high-performance precision peptide that enhances the skin’s natural self-repair mechanisms for adaptive collagen renewal. It adapts concepts from the


collagen-hybridizing peptide (CHP) technology of the US start-up 3Helix into the world of cosmetics. In an in vivo study, several


skin biopsies were taken from five female subjects aged 60-70 at the beginning and end of the application period. After 56 days of using


NeoHelix Regenerate, results demonstrated a 41% reduction in damaged collagen. Additionally, these biopsies


showed an ability to support the body’s own hyaluronic acid levels, rising by 65% over the study period. Meanwhile, SkinNexus


Collag3n introduces a recombinant Collagen III fragment enabled through a collaboration with Bota Biosciences, a global leader in physical AI-driven biomanufacturing In clinical studies with


female subjects aged 53-70, topical application of SkinNexus Collag3n demonstrated measurable improvements in skin tonicity and sagging appearance, and a visible reduction in the appearance of fine lines and wrinkles after four weeks.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100